Form D · Biotechnology
Escient Pharmaceuticals Inc
San Diego, CA · CIK 0001736699
Offering snapshot reported Nov 28, 2022 · SEC filing
- Reported sold
- $60M Offering amount: $120M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 28, 2022 | Initial | $60,000,006 | No comparison | 22 | SEC filing |
| Sep 18, 2020 | Amendment | $38,750,000 | $6,250,000vs Sep 4, 2020 | 18 | SEC filing |
| Sep 4, 2020 | Initial | $32,500,000 | No comparison | 17 | SEC filing |
| Apr 9, 2018 | Initial | $10,000,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-465945
The total offering amount is fully committed by investors participating in the initial closing (the "Investors"). The above noted remainder of the offering will be sold to the Investors upon satisfaction or waiver of certain milestone conditions.
Source: Form D, filed Nov 28, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alain Baron | Director, Executive |
| Marcus Boehm | Executive |
| Kathleen Sereda Glaub | Director |
| Joshua Grass | Director, Executive |
| Jason Hafler | Director |
| Peter Hirth | Director |
| Jeen Joo Kang | Director |
| Aaron Mishel | Executive |
| Kevin Raidy | Director |
| Andrew Schwab | Director |
| Robert Tjian | Director |
| Charles Zuker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10578 Science Center Drive Suite 250
San Diego, CA, 92121
San Diego, CA, 92121